| Sephora | 72.7 | 6 | 7 |
| ASOS | 65.6 | 6 | 4 |
| Comparably | 60.0 | 16 | 0 |
| La Roche-Posay | 53.8 | 3 | 4 |
| Chanel | 52.6 | 11 | 0 |
| Sally Beauty Holdings | 50.4 | 3 | 3 |
| Lemon8 | 44.0 | 7 | 0 |
| Berne Convention for the Protection of Literary and Artistic Works | 41.2 | 6 | 0 |
| Shopify | 41.2 | 6 | 0 |
| Membership Rewards | 40.0 | 0 | 13 |
| Aveeno | 39.9 | 2 | 2 |
| Ipsy | 39.9 | 2 | 2 |
| Credo | 39.9 | 2 | 2 |
| Mecca | 39.9 | 2 | 2 |
| Fresh natural cosmetics | 39.9 | 2 | 2 |
| L'Occitane en Provence | 39.1 | 1 | 4 |
| Apple Creator Studio | 38.9 | 0 | 12 |
| The Body Shop | 37.9 | 5 | 0 |
| Luisa Via Roma | 37.9 | 5 | 0 |
| BaiduWiki | 37.9 | 5 | 0 |
| The New York Times | 34.1 | 4 | 0 |
| Cosmopolitan | 34.1 | 4 | 0 |
| Wired | 34.1 | 4 | 0 |
| Clarins | 34.1 | 4 | 0 |
| CNN.com | 34.1 | 4 | 0 |
| Community Health Network | 34.1 | 4 | 0 |
| Shein | 34.1 | 4 | 0 |
| nytimes.com | 34.1 | 4 | 0 |
| Bath & Body Works | 33.8 | 2 | 1 |
| Nu Skin Enterprises | 33.8 | 2 | 1 |
| Neutrogena | 33.8 | 2 | 1 |
| Make-up Art Cosmetics | 33.8 | 2 | 1 |
| Birchbox | 33.8 | 2 | 1 |
| Make Up For Ever | 33.8 | 2 | 1 |
| Beautycounter | 33.8 | 2 | 1 |
| Charlotte Tilbury Beauty | 33.8 | 2 | 1 |
| Color Street | 33.8 | 2 | 1 |
| No7 product line | 31.3 | 1 | 2 |
| Rolling Stone | 29.4 | 3 | 0 |
| New York | 29.4 | 3 | 0 |
| The Medieval Review | 29.4 | 3 | 0 |
| Elite Daily | 29.4 | 3 | 0 |
| Semrush | 29.4 | 3 | 0 |
| Black Diaspora Review | 29.4 | 3 | 0 |
| The New York Times Games | 29.4 | 3 | 0 |
| Dove | 25.2 | 1 | 1 |
| CoverGirl | 25.2 | 1 | 1 |
| Kiehl's | 25.2 | 1 | 1 |
| NARS Cosmetics | 25.2 | 1 | 1 |
| Aesop | 25.2 | 1 | 1 |
| Bluemercury | 25.2 | 1 | 1 |
| Cetaphil | 25.2 | 1 | 1 |
| Dollar Tree | 25.2 | 1 | 1 |
| Origins Natural Resources, Inc. | 25.2 | 1 | 1 |
| Redken | 25.2 | 1 | 1 |
| SkinCeuticals | 25.2 | 1 | 1 |
| Space NK | 25.2 | 1 | 1 |
| Superdrug | 25.2 | 1 | 1 |
| Ulta Beauty | 25.2 | 1 | 1 |
| Beauty Brands | 25.2 | 1 | 1 |
| Dermalogica Inc. | 25.2 | 1 | 1 |
| Dermstore | 25.2 | 1 | 1 |
| Nykaa | 25.2 | 1 | 1 |
| CeraVe | 25.2 | 1 | 1 |
| Rituals | 25.2 | 1 | 1 |
| Lime Crime | 25.2 | 1 | 1 |
| Il Makiage | 25.2 | 1 | 1 |
| Haus Laboratories | 25.2 | 1 | 1 |
| Morphe | 25.2 | 1 | 1 |
| Bobbi Brown | 25.2 | 1 | 1 |
| Cosmo Prof | 25.2 | 1 | 1 |
| Juvia's Place | 25.2 | 1 | 1 |
| OUAI | 25.2 | 1 | 1 |
| Hairhouse | 25.2 | 1 | 1 |
| Florence by Mills | 25.2 | 1 | 1 |
| SalonCentric | 25.2 | 1 | 1 |
| Susanne Kaufmann | 25.2 | 1 | 1 |
| Living Proof | 25.2 | 1 | 1 |
| Beauty Pie | 25.2 | 1 | 1 |
| shadetwin.app | 25.2 | 1 | 1 |
| shadetwin | 25.2 | 1 | 1 |
| Public Goods | 25.2 | 1 | 1 |
| cosmetic shop | 24.4 | 0 | 4 |
| hair styling product | 24.4 | 0 | 4 |
| cosmetic shop chain | 24.4 | 0 | 4 |
| Mon Platin Professional | 24.4 | 0 | 4 |
| Fandom | 23.3 | 2 | 0 |
| IKEA | 23.3 | 2 | 0 |
| Q58024 | 23.3 | 2 | 0 |
| The Hollywood Reporter | 23.3 | 2 | 0 |
| Belk | 23.3 | 2 | 0 |
| Today | 23.3 | 2 | 0 |
| Vogue | 23.3 | 2 | 0 |
| Good Housekeeping | 23.3 | 2 | 0 |
| World Intellectual Property Organization | 23.3 | 2 | 0 |
| Bobbi Brown | 23.3 | 2 | 0 |
| Glamour | 23.3 | 2 | 0 |
| Q483551 | 23.3 | 2 | 0 |
| Deloitte | 23.3 | 2 | 0 |
| Christian Dior | 23.3 | 2 | 0 |
| The New York Times International Edition | 23.3 | 2 | 0 |
| Marie Claire | 23.3 | 2 | 0 |
| Bloomberg Businessweek | 23.3 | 2 | 0 |
| Patent Law Treaty | 23.3 | 2 | 0 |
| Groupon | 23.3 | 2 | 0 |
| Target Corporation | 23.3 | 2 | 0 |
| Kendra | 23.3 | 2 | 0 |
| Lush | 23.3 | 2 | 0 |
| Net-a-Porter | 23.3 | 2 | 0 |
| Sam's Club | 23.3 | 2 | 0 |
| Why The Future Doesn't Need Us | 23.3 | 2 | 0 |
| Bloomberg Terminal | 23.3 | 2 | 0 |
| The New York Times Book Review | 23.3 | 2 | 0 |
| Claire's | 23.3 | 2 | 0 |
| Overstock.com | 23.3 | 2 | 0 |
| Rite Aid | 23.3 | 2 | 0 |
| Sara Sidner | 23.3 | 2 | 0 |
| Yoox Net-a-Porter Group | 23.3 | 2 | 0 |
| Yahoo! Finance | 23.3 | 2 | 0 |
| Business Mirror | 23.3 | 2 | 0 |
| Center for Drug Evaluation and Research | 23.3 | 2 | 0 |
| Crossfire | 23.3 | 2 | 0 |
| e.l.f. Cosmetics | 23.3 | 2 | 0 |
| Fareed Zakaria GPS | 23.3 | 2 | 0 |
| Fox & Friends | 23.3 | 2 | 0 |
| Nylon | 23.3 | 2 | 0 |
| Justice with Judge Jeanine | 23.3 | 2 | 0 |
| KXAN-TV | 23.3 | 2 | 0 |
| The Philippine Star | 23.3 | 2 | 0 |
| Miss Selfridge | 23.3 | 2 | 0 |
| Museum Anthropology Review | 23.3 | 2 | 0 |
| PopSugar | 23.3 | 2 | 0 |
| Reliable Sources | 23.3 | 2 | 0 |
| rue21 | 23.3 | 2 | 0 |
| Stifel | 23.3 | 2 | 0 |
| TheStreet | 23.3 | 2 | 0 |
| Trustpilot | 23.3 | 2 | 0 |
| Weekend Today | 23.3 | 2 | 0 |
| E! | 23.3 | 2 | 0 |
| Playing with Fire | 23.3 | 2 | 0 |
| Escape Club | 23.3 | 2 | 0 |
| PureWow | 23.3 | 2 | 0 |
| Untold | 23.3 | 2 | 0 |
| Botched | 23.3 | 2 | 0 |
| Gutfeld! | 23.3 | 2 | 0 |
| WAGS LA | 23.3 | 2 | 0 |
| The Sixties | 23.3 | 2 | 0 |
| CNNGo | 23.3 | 2 | 0 |
| United Shades of America | 23.3 | 2 | 0 |
| Instacart | 23.3 | 2 | 0 |
| NYX Professional Makeup | 23.3 | 2 | 0 |
| Blue Apron | 23.3 | 2 | 0 |
| Hindsight: Journal of Optometry History | 23.3 | 2 | 0 |
| International Journal of Designs for Learning | 23.3 | 2 | 0 |
| Axios | 23.3 | 2 | 0 |
| Forbes 30 Under 30 | 23.3 | 2 | 0 |
| Boohoo Group | 23.3 | 2 | 0 |
| Megyn Kelly Today | 23.3 | 2 | 0 |
| The World is Our Home | 23.3 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 23.3 | 2 | 0 |
| bidirectional encoder representations from transformers | 23.3 | 2 | 0 |
| Honchō | 23.3 | 2 | 0 |
| Fashion Nova | 23.3 | 2 | 0 |
| Chasing Life | 23.3 | 2 | 0 |
| Indiana University journal of undergraduate research | 23.3 | 2 | 0 |
| The David Rubenstein Show | 23.3 | 2 | 0 |
| Locarno Agreement Establishing an International Classification for Industrial Designs | 23.3 | 2 | 0 |
| Raas International Clothing Inc | 23.3 | 2 | 0 |
| Folklore and folk music archivist | 23.3 | 2 | 0 |
| Blåhaj | 23.3 | 2 | 0 |
| Bloomberg Bpool | 23.3 | 2 | 0 |
| Standing Committee on Copyright and Related Rights | 23.3 | 2 | 0 |
| WIPO Magazine | 23.3 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 23.3 | 2 | 0 |
| Forbes ASAP | 23.3 | 2 | 0 |
| Global Innovation Index 2023 | 23.3 | 2 | 0 |
| Marketing Crafts and Visual Arts: The Role of Intellectual Property | 23.3 | 2 | 0 |
| WebMD Magazine | 23.3 | 2 | 0 |
| The Global Publishing Industry in 2022 | 23.3 | 2 | 0 |
| Artificial Intelligence and Intellectual Property: An Economic Perspective | 23.3 | 2 | 0 |
| Equate | 23.3 | 2 | 0 |
| WIPO Technology Trends 2019 | 23.3 | 2 | 0 |
| Intellectual Property Valuation in Biotechnology and Pharmaceuticals | 23.3 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 23.3 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 23.3 | 2 | 0 |
| Whois.com | 23.3 | 2 | 0 |
| Jordan/Zalaznick Advisers Inc. | 23.3 | 2 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 23.3 | 2 | 0 |
| Fashionista | 23.3 | 2 | 0 |
| beauty salon | 21.0 | 0 | 3 |
| cleanser | 21.0 | 0 | 3 |
| American journal of contact dermatitis : official journal of the American Contact Dermatitis Society | 21.0 | 0 | 3 |
| Exposure data for cosmetic products: lipstick, body lotion, and face cream | 21.0 | 0 | 3 |
| Exposure data for personal care products: hairspray, spray perfume, liquid foundation, shampoo, body wash, and solid antiperspirant | 21.0 | 0 | 3 |
| Accounting for intended use application in characterizing the contributions of cyclopentasiloxane (D5) to aquatic loadings following personal care product use: Antiperspirants, skin care products and hair care products | 21.0 | 0 | 3 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser | 21.0 | 0 | 3 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50 | 21.0 | 0 | 3 |
| Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test | 21.0 | 0 | 3 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash | 21.0 | 0 | 3 |
| beauty store | 21.0 | 0 | 3 |
| head hair type | 21.0 | 0 | 3 |
| An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream | 21.0 | 0 | 3 |
| bath & body gift set | 21.0 | 0 | 3 |
| nail polish drying drops & spray | 21.0 | 0 | 3 |
| nail polish thinner | 21.0 | 0 | 3 |
| hair styling tool accessory | 21.0 | 0 | 3 |
| hair curler clips & pin | 21.0 | 0 | 3 |
| hair dryer accessory | 21.0 | 0 | 3 |
| hair iron accessory | 21.0 | 0 | 3 |
| hair styling tool | 21.0 | 0 | 3 |
| combs & brush | 21.0 | 0 | 3 |
| hair styling tool set | 21.0 | 0 | 3 |
| makeup remover | 21.0 | 0 | 3 |
| L'Atelier du Sourcil | 21.0 | 0 | 3 |
| Sustainable Sourcing of Organic Skincare Ingredients: A Critical Analysis of Ethical Concerns and Environmental Implications | 21.0 | 0 | 3 |
| Decorté | 21.0 | 0 | 3 |
| Beauty Favours | 21.0 | 0 | 3 |
| DFRACT | 21.0 | 0 | 3 |
| DFRACT | 21.0 | 0 | 3 |
| Nivea | 16.7 | 0 | 2 |
| Aeroplan | 16.7 | 0 | 2 |
| Euro starter kits | 16.7 | 0 | 2 |
| toner | 16.7 | 0 | 2 |
| lip liner | 16.7 | 0 | 2 |
| ethical consumerism | 16.7 | 0 | 2 |
| face powder | 16.7 | 0 | 2 |
| Revlon | 16.7 | 0 | 2 |
| irritant dermatitis | 16.7 | 0 | 2 |
| natural cosmetics | 16.7 | 0 | 2 |
| Kérastase | 16.7 | 0 | 2 |
| kinky hair | 16.7 | 0 | 2 |
| Brylcreem | 16.7 | 0 | 2 |
| Artistry | 16.7 | 0 | 2 |
| American Journal of Clinical Oncology | 16.7 | 0 | 2 |
| Brazilian hair straightening | 16.7 | 0 | 2 |
| highlighter | 16.7 | 0 | 2 |
| Americas Best Value Inn | 16.7 | 0 | 2 |
| Conair Corporation | 16.7 | 0 | 2 |
| anti-aging cream | 16.7 | 0 | 2 |
| hairstyling product | 16.7 | 0 | 2 |
| Pomade acne | 16.7 | 0 | 2 |
| setting spray | 16.7 | 0 | 2 |
| sustainable packaging | 16.7 | 0 | 2 |
| OXY | 16.7 | 0 | 2 |
| dry shampoo | 16.7 | 0 | 2 |
| false nail | 16.7 | 0 | 2 |
| make-up brush | 16.7 | 0 | 2 |
| EOS Products, LLC | 16.7 | 0 | 2 |
| Allergic contact dermatitis to synthetic rubber gloves: changing trends in patch test reactions to accelerators | 16.7 | 0 | 2 |
| AG Hair Care | 16.7 | 0 | 2 |
| Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics | 16.7 | 0 | 2 |
| Shea Moisture | 16.7 | 0 | 2 |
| promotional code | 16.7 | 0 | 2 |
| Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example | 16.7 | 0 | 2 |
| Stash Hotel Rewards | 16.7 | 0 | 2 |
| Cancer clinical trials | 16.7 | 0 | 2 |
| Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature | 16.7 | 0 | 2 |
| Allergic contact dermatitis to cocamidopropylbetaine in hair shampoo | 16.7 | 0 | 2 |
| A review of perineal skin care protocols and skin barrier product use | 16.7 | 0 | 2 |
| Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group | 16.7 | 0 | 2 |
| Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis—A Meta-analysis of Comparative and Non-comparative Clinical Trials | 16.7 | 0 | 2 |
| The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD) | 16.7 | 0 | 2 |
| Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money | 16.7 | 0 | 2 |
| Improvement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract | 16.7 | 0 | 2 |
| Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. | 16.7 | 0 | 2 |
| Clinical Efficacy and Tolerability of Sumatriptan Tablet and Suppository in the Acute Treatment of Migraine: A Review of Data from Clinical Trials | 16.7 | 0 | 2 |
| Positive patch test reactions to carba mix and iodopropynyl butylcarbamate: data from the North American Contact Dermatitis Group, 1998-2008. | 16.7 | 0 | 2 |
| Occupational contact dermatitis in hairdressers: an analysis of patch test data from the Danish contact dermatitis group, 2002-2011. | 16.7 | 0 | 2 |
| Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group | 16.7 | 0 | 2 |
| Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis Group | 16.7 | 0 | 2 |
| First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to just | 16.7 | 0 | 2 |
| Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials. | 16.7 | 0 | 2 |
| Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow | 16.7 | 0 | 2 |
| Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment | 16.7 | 0 | 2 |
| Allergic contact dermatitis from pharmaceutical grade BHA in Timodine, with no patch test reaction to analytical grade BHA. | 16.7 | 0 | 2 |
| Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. | 16.7 | 0 | 2 |
| Clinical trials with haemopoietic growth factors | 16.7 | 0 | 2 |
| Positive patch test reactions to lanolin: cross-sectional data from the north american contact dermatitis group, 1994 to 2006. | 16.7 | 0 | 2 |
| The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical t | 16.7 | 0 | 2 |
| Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. | 16.7 | 0 | 2 |
| Assessment of the clinical efficacy of a hyaluronic acid-based deep wrinkle filler using new instrumental methods | 16.7 | 0 | 2 |
| A comparative study of allergic contact dermatitis by patch test versus reflectance confocal laser microscopy, with nickel and cobalt | 16.7 | 0 | 2 |
| Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI | 16.7 | 0 | 2 |
| Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting | 16.7 | 0 | 2 |
| Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition | 16.7 | 0 | 2 |
| Common Allergens Identified Based on Patch Test Results in Patients with Suspected Contact Dermatitis of the Scalp. | 16.7 | 0 | 2 |
| Allergic contact dermatitis pattern in Kuwait: nickel leads the pack. In-depth analysis of nickel allergy based on the results from a large prospective patch test series report | 16.7 | 0 | 2 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 16.7 | 0 | 2 |
| Clinical efficacy of a spray containing hyaluronic Acid and dexpanthenol after surgery in the nasal cavity (septoplasty, simple ethmoid sinus surgery, and turbinate surgery) | 16.7 | 0 | 2 |
| Treating the patient with multiple cosmetic product allergies. A problem-oriented approach to sensitive skin | 16.7 | 0 | 2 |
| Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies | 16.7 | 0 | 2 |
| Review of Preclinical and Clinical Results with Vascular Endothelial Growth Factors for Therapeutic Angiogenesis. | 16.7 | 0 | 2 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 16.7 | 0 | 2 |
| Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group | 16.7 | 0 | 2 |
| Occupational allergic contact dermatitis and patch test results of leather workers at two Indonesian tanneries. | 16.7 | 0 | 2 |
| Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results | 16.7 | 0 | 2 |
| Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials | 16.7 | 0 | 2 |
| Validity and ethics of the human 4-h patch test as an alternative method to assess acute skin irritation potential | 16.7 | 0 | 2 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 16.7 | 0 | 2 |
| Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis | 16.7 | 0 | 2 |
| Allergic contact dermatitis from ophthalmic products: can pre-treatment with sodium lauryl sulfate increase patch test sensitivity? | 16.7 | 0 | 2 |
| Skin Irritation to Glass Wool or Continuous Glass Filaments as Observed by a Patch Test among Human Japanese Volunteers | 16.7 | 0 | 2 |
| Clinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials | 16.7 | 0 | 2 |
| Translating research to promote healthy aging: the complementary role of longitudinal studies and clinical trials | 16.7 | 0 | 2 |
| Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage | 16.7 | 0 | 2 |
| Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation | 16.7 | 0 | 2 |
| Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact De | 16.7 | 0 | 2 |
| Evaluation of the histologic characteristics of patch test confirmed allergic contact dermatitis | 16.7 | 0 | 2 |
| In vivo assessment of the effect of a cream containing Avena Rhealba® extract and hyaluronic acid on the restoration of the skin barrier in de-epidermised skin produced with an erbium-YAG laser | 16.7 | 0 | 2 |
| Improvement in skin wrinkles using a preparation containing human growth factors and hyaluronic acid serum | 16.7 | 0 | 2 |
| Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair. | 16.7 | 0 | 2 |
| Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis | 16.7 | 0 | 2 |
| Analysis of skin patch test results and metalloproteinase-2 levels in a patient with contact dermatitis | 16.7 | 0 | 2 |
| Which interventions offer best value for money in primary prevention of cardiovascular disease? | 16.7 | 0 | 2 |
| Estimation of optimalb-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer | 16.7 | 0 | 2 |
| "You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa | 16.7 | 0 | 2 |
| Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry | 16.7 | 0 | 2 |
| Safety and efficacy of personal care products containing colloidal oatmeal | 16.7 | 0 | 2 |
| Identification of Major Active Ingredients Responsible for Burn Wound Healing of Centella asiatica Herbs | 16.7 | 0 | 2 |
| Clinical trials of myeloid growth factors | 16.7 | 0 | 2 |
| Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair | 16.7 | 0 | 2 |
| Healthy aging: can clinical trials deliver? | 16.7 | 0 | 2 |
| Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone | 16.7 | 0 | 2 |
| Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. | 16.7 | 0 | 2 |
| Patch test standard series recommended by the Brazilian Contact Dermatitis Study Group during the 2006-2011 period | 16.7 | 0 | 2 |
| Patch test results in patients with allergic contact dermatitis in the Podlasie region. | 16.7 | 0 | 2 |
| The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial | 16.7 | 0 | 2 |
| Does a home-based strength and balance programme in people aged > or =80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions | 16.7 | 0 | 2 |
| 2010 GeekDad Holiday Gift Guide #2 | 16.7 | 0 | 2 |
| Hematopoietic growth factors: a summary of their biology in tissue culture, animals, and clinical trials | 16.7 | 0 | 2 |
| Add-on diagnostic tool for allergic contact dermatitis: the strip patch test. | 16.7 | 0 | 2 |
| Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic | 16.7 | 0 | 2 |
| Systematic Review of Clinical Trials of Small- and Large-Gel-Particle Hyaluronic Acid Injectable Fillers for Aesthetic Soft Tissue Augmentation | 16.7 | 0 | 2 |
| Clinical efficacy of growth factors to enhance tissue repair in oral and maxillofacial reconstruction: a systematic review | 16.7 | 0 | 2 |
| Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management | 16.7 | 0 | 2 |
| Recommendation to include methylisothiazolinone in the European baseline patch test series--on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by cosmetic products | 16.7 | 0 | 2 |
| The Evolution of Skin Pigmentation and Hair Texture in People of African Ancestry | 16.7 | 0 | 2 |
| Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials | 16.7 | 0 | 2 |
| Polyphenols as active ingredients for cosmetic products | 16.7 | 0 | 2 |
| Patch test results in 542 patients with suspected contact dermatitis in Turkey | 16.7 | 0 | 2 |
| Contact dermatitis after implantable cardiac defibrillator implantation for ventricular tachycardia | 16.7 | 0 | 2 |
| Brief analysis of causes of sensitive skin and advances in evaluation of anti‐allergic activity of cosmetic products | 16.7 | 0 | 2 |
| Occupational Contact Dermatitis: Workers' Compensation Patch Test Results of Portland, Oregon, 2005-2014. | 16.7 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 16.7 | 0 | 2 |
| Hyaluronic Acid Gel-Based Scaffolds as Potential Carrier for Growth Factors: An In Vitro Bioassay on Its Osteogenic Potential. | 16.7 | 0 | 2 |
| Survey of Occupational Allergic Contact Dermatitis and Patch Test among Clothing Employees in Beijing. | 16.7 | 0 | 2 |
| IN VIVO EVALUATION OF SKIN IRRITATION POTENTIAL, MELASMA AND SEBUM CONTENT FOLLOWING LONG TERM APPLICATION OF SKIN CARE CREAM IN HEALTHY ADULTS, USING NON-INVASIVE BIOMETROLOGICAL TECHNIQUES | 16.7 | 0 | 2 |
| Getting the best value for money in health care | 16.7 | 0 | 2 |
| Late-onset robust curly hair growth in a patient with BRAF-mutated metastatic melanoma responding to dabrafenib | 16.7 | 0 | 2 |
| Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care | 16.7 | 0 | 2 |
| The Use of Lipohydroxy Acid in Skin Care and Acne Treatment | 16.7 | 0 | 2 |
| The anti‐inflammatory effect of cherry blossom extract (Prunus yedoensis) used in soothing skincare product | 16.7 | 0 | 2 |
| Exogenous Factors in Skin Barrier Repair | 16.7 | 0 | 2 |
| Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis | 16.7 | 0 | 2 |
| Effects of hyaluronic acid combined with anti-inflammatory drugs compared with hyaluronic acid alone, in clinical trials and experiments in osteoarthritis: a systematic review and meta-analysis. | 16.7 | 0 | 2 |
| Comparison of metrological techniques for evaluation of the impact of a cosmetic product containing hyaluronic acid on the properties of skin surface | 16.7 | 0 | 2 |
| Will a single periarticular lidocaine–corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis? | 16.7 | 0 | 2 |
| Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials | 16.7 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results 2013-2014. | 16.7 | 0 | 2 |
| Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis | 16.7 | 0 | 2 |
| Obtaining best value for money in nutrition: an emerging new priority for the urban poor | 16.7 | 0 | 2 |
| Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease | 16.7 | 0 | 2 |
| Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial | 16.7 | 0 | 2 |
| Re "International survey on skin patch test procedures, attitudes and interpretation" L.K. Tanno et al., WAOJ (2016) 9:8. | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet. | 16.7 | 0 | 2 |
| Diclofenac/misoprostol. A review of the major clinical trials evaluating its clinical efficacy and upper gastrointestinal tolerability in rheumatoid arthritis and osteoarthritis. | 16.7 | 0 | 2 |
| Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials. | 16.7 | 0 | 2 |
| A review of calculus clinical efficacy studies. | 16.7 | 0 | 2 |
| Human Cumulative Irritation Tests of Common Preservatives Used in Personal Care Products: A Retrospective Analysis of Over 45 000 Subjects | 16.7 | 0 | 2 |
| The Spanish standard patch test series: 2016 update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). | 16.7 | 0 | 2 |
| Quantitative risk assessment of the aggregate dermal exposure to the sensitizing fragrance geraniol in personal care products and household cleaning agents | 16.7 | 0 | 2 |
| Hematopoietic growth factors and chemoprotectants: should we move toward a two-step process for phase I clinical trials in oncology? | 16.7 | 0 | 2 |
| Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products | 16.7 | 0 | 2 |
| A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA Copolymer. | 16.7 | 0 | 2 |
| Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe - analyses of the European Surveillance System on Contact Allergy network, 2002-2010. | 16.7 | 0 | 2 |
| A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a fluoride dentifrice containing triclosan and PVM/MA copolymer | 16.7 | 0 | 2 |
| North American contact dermatitis group patch test results: 2011-2012. | 16.7 | 0 | 2 |
| Tolerability of a Skin Care Regimen Formulated for Acne‐Prone Skin in Children | 16.7 | 0 | 2 |
| Comparison of Marketed Cosmetic Products Constituents with the Antigens Included in Cosmetic-related Patch Test | 16.7 | 0 | 2 |
| Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin | 16.7 | 0 | 2 |
| A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. | 16.7 | 0 | 2 |
| Allergic contact dermatitis from a cream containing Centella asiatica extract | 16.7 | 0 | 2 |
| Changes in synovial fluid biomarkers and clinical efficacy of intra‐articular injections of hyaluronic acid for patients with knee osteoarthritis | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by (meth)acrylates in long-lasting nail polish - are we facing a new epidemic in the beauty industry? | 16.7 | 0 | 2 |
| Statistics in question. Assessing clinical trials--trial size. | 16.7 | 0 | 2 |
| Patch Test Results from an Occupational and Contact Dermatitis Clinic in a Tertiary Care Hospital of Southern India: A Retrospective Study | 16.7 | 0 | 2 |
| Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients | 16.7 | 0 | 2 |
| Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner | 16.7 | 0 | 2 |
| Contact dermatitis due to Centella asiatica | 16.7 | 0 | 2 |
| Semipermeable glove membranes--effects on skin barrier repair following SLS irritation | 16.7 | 0 | 2 |
| Shoe contact dermatitis from dimethyl fumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure. | 16.7 | 0 | 2 |
| Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction | 16.7 | 0 | 2 |
| Ambroxol-induced systemic contact dermatitis confirmed by positive patch test | 16.7 | 0 | 2 |
| Cumulative irritation patch test of sanitary pads on sensitive skin | 16.7 | 0 | 2 |
| Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population | 16.7 | 0 | 2 |
| Methylchloroisothiazolinone and Methylisothiazolinone Allergic Contact Dermatitis and the Effect of Patch Test Concentration | 16.7 | 0 | 2 |
| Sanitary napkin contact dermatitis of the vulva: location-dependent differences in skin surface conditions may play a role in negative patch test results | 16.7 | 0 | 2 |
| Allergic contact dermatitis due to topical imidazole antimycotics. The sensitizing ability of active ingredients and cross-sensitivity | 16.7 | 0 | 2 |
| Reduced levels of glutathione S-transferases in patch test reactions to dithranol and sodium lauryl sulphate as demonstrated by quantitative immunocytochemistry: evidence for oxidative stress in acute irritant contact dermatitis | 16.7 | 0 | 2 |
| Patch test results with tixocortol pivalate and budesonide in Germany and Austria | 16.7 | 0 | 2 |
| Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements | 16.7 | 0 | 2 |
| Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group | 16.7 | 0 | 2 |
| Comment on the contribution by P. Gottlober et al.: "Allergic contact dermatitis in beauty shop customers" | 16.7 | 0 | 2 |
| Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? | 16.7 | 0 | 2 |
| Contact dermatitis from vitamin C in a cosmetic anti‐aging cream | 16.7 | 0 | 2 |
| Short term study of human skin irritation by single application closed patch test: assessment of four multiple emulsion formulations loaded with botanical extracts. | 16.7 | 0 | 2 |
| Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. | 16.7 | 0 | 2 |
| The profile of patch test reactions to common contact allergens is related to sex. | 16.7 | 0 | 2 |
| Lyral has been included in the patch test standard series in Germany | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by a mixture of sodium myristoyl sarcosinate and sodium myristoate in a cosmetic product | 16.7 | 0 | 2 |
| P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption | 16.7 | 0 | 2 |
| Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*. | 16.7 | 0 | 2 |
| Concomitant patch test reactions to mercapto mix and mercaptobenzothiazole: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. | 16.7 | 0 | 2 |
| Positive patch test reactions in older individuals: Retrospective analysis from the North American Contact Dermatitis Group, 1994-2008 | 16.7 | 0 | 2 |
| Histologic aspects of patch test reactions in allergic contact dermatitis | 16.7 | 0 | 2 |
| Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety?: By Vaquerizo V. et al. | 16.7 | 0 | 2 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 16.7 | 0 | 2 |
| Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007. | 16.7 | 0 | 2 |
| Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid | 16.7 | 0 | 2 |
| Allergic contact dermatitis due to phenylephrine hydrochloride, with an unusual patch test reaction | 16.7 | 0 | 2 |
| Comparison of patch test contact sensitivity to acetone and aqueous extracts of Parthenium hysterophorus in patients with airborne contact dermatitis | 16.7 | 0 | 2 |
| Effect of semipermeable membranes on skin barrier repair following tape stripping | 16.7 | 0 | 2 |
| Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group | 16.7 | 0 | 2 |
| Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). | 16.7 | 0 | 2 |
| Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test | 16.7 | 0 | 2 |
| Characteristics of patch test reactions to common preservatives incorporated in petrolatum and water, respectively | 16.7 | 0 | 2 |
| The American Academy of Dermatology patch test series for contact dermatitis | 16.7 | 0 | 2 |
| Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in panama. | 16.7 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for 2007-2008. | 16.7 | 0 | 2 |
| Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies | 16.7 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 16.7 | 0 | 2 |
| Growth factors expression in hyaluronic acid fat graft myringoplasty | 16.7 | 0 | 2 |
| Scratch-patch test for the diagnosis of allergic contact dermatitis to aciclovir | 16.7 | 0 | 2 |
| The Association of Race/Ethnicity and Patch Test Results: North American Contact Dermatitis Group, 1998-2006. | 16.7 | 0 | 2 |
| Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. | 16.7 | 0 | 2 |
| Best value for money in triptans | 16.7 | 0 | 2 |
| Acetylenic polymers for hair styling products | 16.7 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 16.7 | 0 | 2 |
| Comparative assessment of the acute skin irritation potential of detergent formulations using a novel human 4-h patch test method. | 16.7 | 0 | 2 |
| Addendum to Geier J, Lessmann H, Uter W, Schnuch A. Are concomitant patch test reactions to epoxy resin and BIS-GMA indicative of cross reactivity? Contact Dermatitis 2007: 57: 376-380. | 16.7 | 0 | 2 |
| Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. | 16.7 | 0 | 2 |
| Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. | 16.7 | 0 | 2 |
| Biocompounds from rapeseed oil industry co-stream as active ingredients for skin care applications | 16.7 | 0 | 2 |
| Crude 4-methylcyclohexanemethanol (MCHM) did not cause skin irritation in humans in 48-h patch test. | 16.7 | 0 | 2 |
| Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA | 16.7 | 0 | 2 |
| Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils | 16.7 | 0 | 2 |
| Analysis of sensitive skin barrier function: basic indicators and sebum composition | 16.7 | 0 | 2 |
| Hydrophilic Dogwood Extracts as Materials for Reducing the Skin Irritation Potential of Body Wash Cosmetics | 16.7 | 0 | 2 |
| Phytosphingosine enhances moisture level in human skin barrier through stimulation of the filaggrin biosynthesis and degradation leading to NMF formation | 16.7 | 0 | 2 |
| Microplastics releasing from personal care and cosmetic products in China | 16.7 | 0 | 2 |
| Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis. | 16.7 | 0 | 2 |
| Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment | 16.7 | 0 | 2 |
| Risks of Allergic Contact Dermatitis Elicited by Nickel, Chromium, and Organic Sensitizers: Quantitative Models Based on Clinical Patch Test Data | 16.7 | 0 | 2 |
| A low cost, simplified, and scaleable pneumotachograph and face mask for neonatal mouse respiratory measurements | 16.7 | 0 | 2 |
| Biochemical and aerosol characterization of ricin for use in non-clinical efficacy studies. | 16.7 | 0 | 2 |
| Allergic Contact Dermatitis Caused by Acrylates in Long-Lasting Nail Polish | 16.7 | 0 | 2 |
| Clinical Evaluation of a Multi-Modal Facial Serum That Addresses Hyaluronic Acid Levels in Skin | 16.7 | 0 | 2 |
| Transtemporal amygdalohippocampectomy: a novel minimally-invasive technique with optimal clinical results and low cost | 16.7 | 0 | 2 |
| Hyaluronic acid-based hydrogel scaffold without angiogenic growth factors enhances ovarian tissue function after autotransplantation in rats | 16.7 | 0 | 2 |
| The efficacy of a lip balm containing pseudo-ceramide on the dry lips of sensitive skin-conscious subjects | 16.7 | 0 | 2 |
| Non-occupational allergic contact dermatitis caused by long-lasting nail polish kits for home use: 'the tip of the iceberg'. | 16.7 | 0 | 2 |
| Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials. | 16.7 | 0 | 2 |
| Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 2: Guinea pigs challenged with soman | 16.7 | 0 | 2 |
| Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 1: Guinea pigs challenged with VX | 16.7 | 0 | 2 |
| cruelty free cosmetics | 16.7 | 0 | 2 |
| The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo‐controlled clinical trials | 16.7 | 0 | 2 |
| Atopy Associated With Positive Patch Test and Possible Allergic Contact Dermatitis | 16.7 | 0 | 2 |
| Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI). | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by hydroxyacetophenone in a face cream | 16.7 | 0 | 2 |
| Allergic Contact Cheilitis From a Variety of Lip Balm Ingredients | 16.7 | 0 | 2 |
| Basic therapeutics : What are the features of modern personal care products to protect and regenerate the skin barrier? | 16.7 | 0 | 2 |
| hair care product | 16.7 | 0 | 2 |
| The purpuric patch test in patients with allergic contact dermatitis from azo dyes | 16.7 | 0 | 2 |
| Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. | 16.7 | 0 | 2 |
| Colloidal Oatmeal <em>(Avena Sativa)</em> Improves Skin Barrier Through Multi-Therapy Activity | 16.7 | 0 | 2 |
| Patch test results in schoolchildren. Results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) | 16.7 | 0 | 2 |
| A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. | 16.7 | 0 | 2 |
| More positive patch test reactions with larger test chambers? Results from a study group of the German Contact Dermatitis Research Group (DKG). | 16.7 | 0 | 2 |
| Pattern of patch test reactivity among patients with clinical diagnosis of contact dermatitis: a hospital-based study | 16.7 | 0 | 2 |
| Comparison of skin calming effects of cosmetic products containing 4‐t‐butylcyclohexanol or acetyl dipeptide‐1 cetyl ester on capsaicin‐induced facial stinging in volunteers with sensitive skin | 16.7 | 0 | 2 |
| Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety? | 16.7 | 0 | 2 |
| Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis | 16.7 | 0 | 2 |
| Epicutaneous patch test results in children and adults with allergic contact dermatitis in Karlovac county: a retrospective survey | 16.7 | 0 | 2 |
| Female wet workers and contact dermatitis: patch test results and sensitization in North-East Italy. | 16.7 | 0 | 2 |
| Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. | 16.7 | 0 | 2 |
| Thoughts on how to improve the quality of multicentre patch test studies | 16.7 | 0 | 2 |
| Clinical expression of nickel contact dermatitis primed by diagnostic patch test. | 16.7 | 0 | 2 |
| Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation | 16.7 | 0 | 2 |
| The study of human skin irritation of a novel herbal skin care product and ingredients by human single closed patch testing | 16.7 | 0 | 2 |
| Epicutaneous patch test results in patients with allergic contact dermatitis in Karlovac county--a retrospective survey. | 16.7 | 0 | 2 |
| Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. | 16.7 | 0 | 2 |
| Modernizing Regulation of Cosmetic Products: Reintroduction of the Personal Care Products Safety Act. | 16.7 | 0 | 2 |
| Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. | 16.7 | 0 | 2 |
| Symmetrical Intertriginous Skin Eruption in a Patient With Positive Patch Test to Metal: Systemic Contact Dermatitis or Lichen Planus Pigmentosus Inversus? | 16.7 | 0 | 2 |
| Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy | 16.7 | 0 | 2 |
| Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin. | 16.7 | 0 | 2 |
| Survey of Patch Test Business Models in the United States by the American Contact Dermatitis Society | 16.7 | 0 | 2 |
| Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin | 16.7 | 0 | 2 |
| The identification and classification of skin irritation hazard by a human patch test | 16.7 | 0 | 2 |
| The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study | 16.7 | 0 | 2 |
| Hyaluronic acid induces the release of growth factors from platelet-rich plasma | 16.7 | 0 | 2 |
| Patch test reactions to the chinese standard screening allergens in 1,135 patients investigated for allergic contact dermatitis | 16.7 | 0 | 2 |
| Occupational contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone through exposure to filler dust containing this preservative and with a positive patch test reaction to the dust. | 16.7 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 16.7 | 0 | 2 |
| In response to Growth factors expression in hyaluronic acid fat graft myringoplasty | 16.7 | 0 | 2 |
| The perceived obstacles in performing patch test to detect allergic contact dermatitis: a comparison between community allergists and directors of allergy training programs | 16.7 | 0 | 2 |
| Clinical Efficacy Studies of Haloprogin, a New Topical Antimicrobial Agent | 16.7 | 0 | 2 |
| An ex vivo biochemical model to study the antioxidant clinical properties of cosmetic products in human antiaging skin care | 16.7 | 0 | 2 |
| Olive Young | 16.7 | 0 | 2 |
| Results of Hairdressing Series Patch Test in Patients with Allergic Contact Dermatitis to Para-phenylenediamine; Are there any Safe Alternatives? | 16.7 | 0 | 2 |
| Pilot study on a new concept of documenting the clinical relevance of patch test results in contact dermatitis patients | 16.7 | 0 | 2 |
| Production and characterization of hyaluronic acid microparticles for the controlled delivery of growth factors using a spray/dehydration method | 16.7 | 0 | 2 |
| Dentistry and medicine degrees are best value for money | 16.7 | 0 | 2 |
| Hyaluronic Acid, PRP/Growth Factors, and Stem Cells in the Treatment of Osteochondral Lesions | 16.7 | 0 | 2 |
| Clinical Efficacy and Safety in Children with Vesicoureteral Reflux of a Single Injection of Two Different Bulking Agents – Polydimethylsiloxane (Macroplastique) or Dextranomer/Hyaluronic Acid Copolymer (Deflux): A Short-Term Prospective Comparativ | 16.7 | 0 | 2 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 16.7 | 0 | 2 |
| Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers | 16.7 | 0 | 2 |
| Skin care in occupational contact dermatitis of the hands | 16.7 | 0 | 2 |
| Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy | 16.7 | 0 | 2 |
| Strip patch test vs. conventional patch test to detect type IV sensitization in patients with allergic contact dermatitis | 16.7 | 0 | 2 |
| male grooming | 16.7 | 0 | 2 |
| Madison Reed | 16.7 | 0 | 2 |
| Intraarticular Glucose Versus Hyaluronic Acid Injection for Knee Osteoarthrosis | 16.7 | 0 | 2 |
| To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test | 16.7 | 0 | 2 |
| The Crème Shop | 16.7 | 0 | 2 |
| Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products | 16.7 | 0 | 2 |
| A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin | 16.7 | 0 | 2 |
| Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life | 16.7 | 0 | 2 |
| Lactacyd Radiance (Lactic Acid) Prophetic Patch Test | 16.7 | 0 | 2 |
| Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects | 16.7 | 0 | 2 |
| Skin Biophysical Parameters and Patch Test Results in People Predisposing to Xiaotong Tiegao Induced Irritant Contact Dermatitis | 16.7 | 0 | 2 |
| Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccines | 16.7 | 0 | 2 |
| Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis | 16.7 | 0 | 2 |
| Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. | 16.7 | 0 | 2 |
| Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) | 16.7 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch | 16.7 | 0 | 2 |
| Comparative Safety Study of New Sinecort Formulation Versus Positive Control | 16.7 | 0 | 2 |
| A 21-Day Study to Evaluate the Skin Irritation Potential of CCP-020 (Diacerein 1%) Topical Ointment in Healthy Subjects Using a Cumulative Irritant Patch Test Design | 16.7 | 0 | 2 |
| Periodontal Wound Healing With CHX and Hyaluronic Acid | 16.7 | 0 | 2 |
| Acupuncture and Kinesiotherapy on Skin Sensitivity of Patients With Breast Cancer Subject to Chemotherapy With Taxans | 16.7 | 0 | 2 |
| What is the Best Degree of Hyaluronic Acid Crosslinking in Increasing Growth Factors Level of Platelet-Rich Fibrin Lysate? | 16.7 | 0 | 2 |
| Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment | 16.7 | 0 | 2 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30 | 16.7 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion | 16.7 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch | 16.7 | 0 | 2 |
| A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris | 16.7 | 0 | 2 |
| To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products | 16.7 | 0 | 2 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 16.7 | 0 | 2 |
| A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms | 16.7 | 0 | 2 |
| Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid. | 16.7 | 0 | 2 |
| An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis | 16.7 | 0 | 2 |
| Skin Irritation Study of GSK2894512 Cream | 16.7 | 0 | 2 |
| Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product | 16.7 | 0 | 2 |
| Evaluation of contact dermatitis using the TRUE patch test | 16.7 | 0 | 2 |
| Skin and laboratory tests: comparison of the epicutaneous patch test with the TTL and LIF tests in the diagnosis of medicamentous allergic contact dermatitis | 16.7 | 0 | 2 |
| Getting the best value for money in health care | 16.7 | 0 | 2 |
| Increasing the scientific quality of clinical efficacy studies of magnetic resonance imaging | 16.7 | 0 | 2 |
| Microbiological control of preparations for personal hygiene, personal care and improvement of face and body (cosmetic products) | 16.7 | 0 | 2 |
| Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials | 16.7 | 0 | 2 |
| Allergic contact dermatitis from propyl gallate in a lip balm | 16.7 | 0 | 2 |
| Histopathological changes in canine allergic contact dermatitis patch test reactions. A study on spontaneously hypersensitive dogs | 16.7 | 0 | 2 |
| Growth factors, act II: movement into and through clinical trials | 16.7 | 0 | 2 |
| Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis | 16.7 | 0 | 2 |
| PUVA treatment of nickel contact dermatitis: effect on dermatitis, patch test sensitivity, and lymphocyte transformation reactivity | 16.7 | 0 | 2 |
| Patch test of mercury compounds and disinfectant solutions and the clinical picture of mercury contact dermatitis | 16.7 | 0 | 2 |
| Validity of patch test screening trays in the evaluation of patients with allergic contact dermatitis | 16.7 | 0 | 2 |
| Result of patch test and allergic contact dermatitis--statistics over the past six years | 16.7 | 0 | 2 |
| Substances most frequently causing contact dermatitis and skin irritation in Poland. I. Cosmetics | 16.7 | 0 | 2 |
| Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group | 16.7 | 0 | 2 |
| Patch test results in hairdressers with contact dermatitis in Greece (1985-1994) | 16.7 | 0 | 2 |
| Utility objects most frequently causing contact dermatitis and skin irritation in Poland. V. Other products causing eczema | 16.7 | 0 | 2 |
| Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience | 16.7 | 0 | 2 |
| Symposium on comparison of clinical efficacy among various kinds of chemotherapeutic regimens for pulmonary tuberculosis. 3. Methodology of clinical trials | 16.7 | 0 | 2 |
| A clinical and patch test study of contact dermatitis from traditional Chinese medicinal materials | 16.7 | 0 | 2 |
| Allergic contact dermatitis from butoxyethyl nicotinic acid and Centella asiatica extract | 16.7 | 0 | 2 |
| Contact dermatitis after calcipotriol and patch test evaluation | 16.7 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica: a new case | 16.7 | 0 | 2 |
| An immunohistochemical study on mild skin irritation induced by a single application of a low-molarity sodium dodecyl sulfate solution: keys to the prevention of irritant contact dermatitis | 16.7 | 0 | 2 |
| Evaluation of a human patch test for the identification and classification of skin irritation potential | 16.7 | 0 | 2 |
| Contact dermatitis from nail polish: an unusual clinical response | 16.7 | 0 | 2 |
| Contact dermatitis, patch test response, and pentoxifyline. What conclusions can be drawn at present? | 16.7 | 0 | 2 |
| The patch test in contact dermatitis | 16.7 | 0 | 2 |
| Patch test in contact dermatitis | 16.7 | 0 | 2 |
| Local action of hyaluronic acid on reparative processes of the connective tissue. Clinical results | 16.7 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica extract | 16.7 | 0 | 2 |
| Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solution. Experimental safety and efficacy studies | 16.7 | 0 | 2 |
| The inorganic components of human hair and their dependence on sex, age, hair color and hair type | 16.7 | 0 | 2 |
| Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis | 16.7 | 0 | 2 |
| Allergic contact dermatitis from cobalt in a beauty product | 16.7 | 0 | 2 |
| Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis | 16.7 | 0 | 2 |
| Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth factors | 16.7 | 0 | 2 |
| Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard | 16.7 | 0 | 2 |
| Patch test materials for mercury allergic contact dermatitis | 16.7 | 0 | 2 |
| Allergic contact dermatitis due to eye drops. Their clinical features and the patch test results | 16.7 | 0 | 2 |
| ROLE OF the patch test in contact dermatitis | 16.7 | 0 | 2 |
| Nail polish allergy. An important differential diagnosis in contact dermatitis | 16.7 | 0 | 2 |
| lontophoretic Patch Test in Allergic Contact Dermatitis: 30 Years’ Experience | 16.7 | 0 | 2 |
| Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation | 16.7 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens | 16.7 | 0 | 2 |
| Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement | 16.7 | 0 | 2 |
| Neauthy | 16.7 | 0 | 2 |
| Dermal Cumulative Irritant Patch Study | 16.7 | 0 | 2 |
| Tinea capitis in two young women: possible favouring role of hair styling products | 16.7 | 0 | 2 |
| Systemic contact dermatitis due to norfloxacin with a positive patch test to quinoline mix | 16.7 | 0 | 2 |
| Occupational allergic contact dermatitis in a patient with a positive patch test to tin | 16.7 | 0 | 2 |
| Associated positive patch test reactions to standard contact allergens | 16.7 | 0 | 2 |
| Clinical efficacy and safety of tazarotene: optimizing clinical results | 16.7 | 0 | 2 |
| The effect of two moisturisers on skin barrier damage in allergic contact dermatitis | 16.7 | 0 | 2 |
| Proteolytic inactivation of transforming growth factor beta3 by elastase in venous leg ulcers: implications for clinical trials using topically-applied peptide growth factors | 16.7 | 0 | 2 |
| Allergic contact dermatitis from 5-fluorouracil with positive intradermal test and doubtful patch test reactions | 16.7 | 0 | 2 |
| Reproducibility of irritant patch test reactions to sodium lauryl sulfate in a double-blind placebo-controlled randomized study using clinical scoring. Results from a study group of the German Contact Dermatitis Research Group (Deutsche Kontaktaller | 16.7 | 0 | 2 |
| PHOTO-CONTACT DERMATITIS. THE PHOTO-PATCH TEST AS A VERIFICATION OF THE PHOTO-ALLERGIC NATURE | 16.7 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 16.7 | 0 | 2 |
| Allergic contact dermatitis from cera alba (purified propolis) in a lip balm and candy | 16.7 | 0 | 2 |
| [Methodological thoughts on clinical efficacy evaluation with multiple clinical trials] | 16.7 | 0 | 2 |
| A high-positive patch test load correlates with further positive patch test reactions irrespective of their location | 16.7 | 0 | 2 |
| Standard patch test results in patients with contact dermatitis in Israel: age and sex differences | 16.7 | 0 | 2 |
| Dynamics of skin barrier repair following topical applications of miconazole nitrate | 16.7 | 0 | 2 |
| Positive patch test reactions to nickel sulphate are not modified by neighbouring negative fragrance patch tests. A multicenter-study by the German contact dermatitis research group | 16.7 | 0 | 2 |
| The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne | 16.7 | 0 | 2 |
| Clinical trials in metastatic hormone-refractory prostate cancer: improving docetaxel therapy by targeting bone-related growth factors | 16.7 | 0 | 2 |
| European Standard Series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004 | 16.7 | 0 | 2 |
| Making repeated clinical trials aiming at finding specific indications is the way for improving clinical efficacy of traditional Chinese medicine | 16.7 | 0 | 2 |
| Determination of skin irritation potential in the human 4-h patch test | 16.7 | 0 | 2 |
| Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test | 16.7 | 0 | 2 |
| Positive patch test reaction without clinical contact dermatitis--what is the best approach in medico-legal evaluation? | 16.7 | 0 | 2 |
| Patch test in Chinese patients with cosmetic allergic contact dermatitis to common cosmetic allergens from a European cosmetic series | 16.7 | 0 | 2 |
| Are adverse skin reactions to cosmetics underestimated in the clinical assessment of contact dermatitis? A prospective study among 1075 patients attending Swedish patch test clinics | 16.7 | 0 | 2 |
| Two cases of contact dermatitis resulting from use of body wash as a skin moisturizer | 16.7 | 0 | 2 |
| Prevalence and 1-year outcome of facial allergic contact dermatitis in patients patch tested in a university hospital | 16.7 | 0 | 2 |
| Allergic contact dermatitis in 191 consecutively patch tested children | 16.7 | 0 | 2 |
| Allergic contact dermatitis to propolis and carnauba wax from lip balm and chewable vitamins in a child | 16.7 | 0 | 2 |
| Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care | 16.7 | 0 | 2 |
| A tool to evaluate rapidly the quality of clinical trials on topical acne treatment | 16.7 | 0 | 2 |
| Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis | 16.7 | 0 | 2 |
| Strong allergic patch test reactions may indicate a general disposition for contact allergy | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by sodium dehydroacetate, not hyaluronic acid, in Ialuset® cream | 16.7 | 0 | 2 |
| Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells | 16.7 | 0 | 2 |
| Result of standard patch test in patients suspected of having allergic contact dermatitis | 16.7 | 0 | 2 |
| New indications for Hyaluronic acid of the NASHA-gel-generation--highlights from aesthetical dermatology in clinical daily routine | 16.7 | 0 | 2 |
| Acute allergic contact dermatitis of the lips from peppermint oil in a lip balm | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by tetrahydroxypropyl ethylenediamine in cosmetic products | 16.7 | 0 | 2 |
| The patch test in contact dermatitis | 16.7 | 0 | 2 |
| Patch test results from a contact dermatitis clinic in North India | 16.7 | 0 | 2 |
| Clinical grade cultivation of human Schwann cell, by the using of human autologous serum instead of fetal bovine serum and without growth factors | 16.7 | 0 | 2 |
| Role of the Patch Test in Contact Dermatitis | 16.7 | 0 | 2 |
| New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams | 16.7 | 0 | 2 |
| Allergic contact dermatitis from heparin-containing gel: use of scratch patch test for diagnosis | 16.7 | 0 | 2 |
| A retrospective study of patients with facial allergic contact dermatitis patch tested with the European standard series in Turkey | 16.7 | 0 | 2 |
| Evaluation of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra | 16.7 | 0 | 2 |
| A rare case of allergic contact dermatitis from silver nitrate in a widely used special patch test marker | 16.7 | 0 | 2 |
| Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals | 16.7 | 0 | 2 |
| The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis | 16.7 | 0 | 2 |
| Rosa centifolia in a 'non-scented' moisturizing body lotion as a cause of allergic contact dermatitis | 16.7 | 0 | 2 |
| Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children | 16.7 | 0 | 2 |
| Clinical efficacy and randomized clinical trials in dysphagia | 16.7 | 0 | 2 |
| Design of clinical trials with patch test allergens in The Netherlands | 16.7 | 0 | 2 |
| Effects of Hydroxydecine® (10-hydroxy-2-decenoic acid) on skin barrier structure and function in vitro and clinical efficacy in the treatment of UV-induced xerosis | 16.7 | 0 | 2 |
| Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid | 16.7 | 0 | 2 |
| Contact dermatitis caused by a footwear label with a positive patch test reaction to 2‐monomethylol phenol | 16.7 | 0 | 2 |
| Understanding skin care and skin barrier function in infants | 16.7 | 0 | 2 |
| Non‐invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL | 16.7 | 0 | 2 |
| An ex vivo human skin model for studying skin barrier repair | 16.7 | 0 | 2 |
| Allergic patch test and contact dermatitis by in vivo reflectance confocal microscopy | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by undisclosed thiurams in a patch test tubular net | 16.7 | 0 | 2 |
| North American Contact Dermatitis Group patch test results: 2009 to 2010 | 16.7 | 0 | 2 |
| Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis | 16.7 | 0 | 2 |
| Elevation of IL-9 in Extreme Patch Test Reactions Suggests It Is an Inflammatory Mediator in Allergic Contact Dermatitis | 16.7 | 0 | 2 |
| Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy? | 16.7 | 0 | 2 |
| Empower: Access to Medicine – Working Towards Early Access | 16.7 | 0 | 2 |
| Contact dermatitis to vitamin K1 in an eye cream | 16.7 | 0 | 2 |
| Limonene hydroperoxide analogues show specific patch test reactions | 16.7 | 0 | 2 |
| The rise in prevalence of contact allergy to methylisothiazolinone in the British Isles | 16.7 | 0 | 2 |
| Patch test results of the dental personnel with contact dermatitis | 16.7 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 16.7 | 0 | 2 |
| A case of acute contact dermatitis induced by formaldehyde in hair‐straightening products | 16.7 | 0 | 2 |
| The effects of benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide), a dual plasmin and urokinase inhibitor, on facial skin barrier function in subjects with sensitive skin | 16.7 | 0 | 2 |
| Efficacy and Safety of Hyaluronic Acid Gel for the Prevention of Intrauterine Adhesion: A Meta-Analysis of Randomized Clinical Trials | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by (meth)acrylates in nail cosmetic products in users and nail technicians - a 5-year study | 16.7 | 0 | 2 |
| Risk Assessment of the Skin Sensitization Induction Potential of Kathon CG in Rinse-off and Leave-on Personal Care and Cosmetic Products | 16.7 | 0 | 2 |
| Declining prevalence of allergic contact dermatitis caused by toslyamide/formaldehyde in nail polish | 16.7 | 0 | 2 |
| Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food | 16.7 | 0 | 2 |
| The role of skin barrier in occupational contact dermatitis | 16.7 | 0 | 2 |
| Pediatric Baseline Patch Test Series: Pediatric Contact Dermatitis Workgroup | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by benzyl salicylate in hair products | 16.7 | 0 | 2 |
| In Reference to Growth factors expression in hyaluronic acid fat graft myringoplasty | 16.7 | 0 | 2 |
| Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study | 16.7 | 0 | 2 |
| Prospective trial for the clinical efficacy of anogenital skin care with miconazole nitrate-containing soap for diaper candidiasis | 16.7 | 0 | 2 |
| Improving the Diagnosis of Allergic Contact Dermatitis Using Patch Test With Gloves | 16.7 | 0 | 2 |
| [Prediction of occupational allergic contact dermatitis induced by formaldehyde by IL17/IL22 secretion cell rest combined with patch test] | 16.7 | 0 | 2 |
| Preservation techniques of stem cells extracellular vesicles: a gate for manufacturing of clinical grade therapeutic extracellular vesicles and long-term clinical trials | 16.7 | 0 | 2 |
| Clinical efficacy of platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review and meta-analysis of randomized placebo-controlled clinical trials | 16.7 | 0 | 2 |
| The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials | 16.7 | 0 | 2 |
| Compromising human skin in vivo and ex vivo to study skin barrier repair | 16.7 | 0 | 2 |
| Statistical Considerations on Clinical Efficacy Studies of Biosimilar for PMDA Submission | 16.7 | 0 | 2 |
| Occupational contact dermatitis in Triveneto: Analysis of patch test data of the North Eastern Italian Database from 1996 to 2016 | 16.7 | 0 | 2 |
| Tertiary prevention of occupational skin diseases: Prevalence of allergic contact dermatitis and pattern of patch test results | 16.7 | 0 | 2 |
| Exploration of microplastics from personal care and cosmetic products and its estimated emissions to marine environment: An evidence from Malaysia | 16.7 | 0 | 2 |
| Natural Does Not Mean Safe-The Dirt on Clean Beauty Products | 16.7 | 0 | 2 |
| Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan) | 16.7 | 0 | 2 |
| Pumpkin seeds, Centella asiatica, Boswellia, Helichrysum, acetate vitamin E, Melaleuca alternifolia and hyaluronic acid phytocomplex monotherapy effects in patients with chronic pelvic pain syndrome | 16.7 | 0 | 2 |
| Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration | 16.7 | 0 | 2 |
| The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis | 16.7 | 0 | 2 |
| Allergic contact dermatitis to personal care products and topical medications in adults with atopic dermatitis | 16.7 | 0 | 2 |
| Everlasting Liquid Lipstick: Reminder to Patch Test Personal Products | 16.7 | 0 | 2 |
| Patch Test Practice Patterns of Members of the American Contact Dermatitis Society | 16.7 | 0 | 2 |
| Clinical efficacy of a chlorhexidine-based mouthrinse containing hyaluronic acid and an antidiscoloration system in patients undergoing flap surgery: A triple-blind, parallel-arm, randomized controlled trial | 16.7 | 0 | 2 |
| Commentary on JAMA Dermatology Editorial: "Natural Does Not Mean Safe-The Dirt on Clean Beauty Products" | 16.7 | 0 | 2 |
| Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials | 16.7 | 0 | 2 |
| Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial | 16.7 | 0 | 2 |
| Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model | 16.7 | 0 | 2 |
| Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops | 16.7 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 16.7 | 0 | 2 |
| Twenty-eight-day follow-up of patch test reactions to p-phenylenediamine and p-phenylenediamine dihydrochloride: A multicentre study on behalf of the European Environmental and Contact Dermatitis Research Group | 16.7 | 0 | 2 |
| Popular over-the-counter cosmeceutical ingredients and their clinical efficacy | 16.7 | 0 | 2 |
| Randomized masked trial of the clinical efficacy of MGO Manuka Honey microemulsion eye cream for the treatment of blepharitis | 16.7 | 0 | 2 |
| Pigmented Facial Contact Dermatitis to Benzyl Salicylate: A Comparative Histopathological and Immunohistochemical Study of the Involved Skin and the Positive Patch Test Site | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by 4-n-butylresorcinol present in a night cream for skin hyperpigmentation | 16.7 | 0 | 2 |
| Clinical efficacy of a new cetylpyridinium chloride-hyaluronic acid-based mouthrinse compared to chlorhexidine and placebo mouthrinses-A 21-day randomized clinical trial | 16.7 | 0 | 2 |
| Clinicoepidemiological and Patch Test Profile of Patients Attending the Contact Dermatitis Clinic of a Tertiary Care Hospital in North India: A 7-Year Retrospective Study | 16.7 | 0 | 2 |
| A seven-year retrospective analysis of patch test data in a cohort of patients with contact dermatitis in Sri Lanka | 16.7 | 0 | 2 |
| Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes | 16.7 | 0 | 2 |
| Clinical and in vitro evaluation of new anti-redness cosmetic products in subjects with winter xerosis and sensitive skin | 16.7 | 0 | 2 |
| Demographics of Men and Minorities in Cosmetic Clinical Trials of Botulinum Toxin and Hyaluronic Acid Fillers | 16.7 | 0 | 2 |
| Clinical evidences of benefits from an advanced skin care routine in comparison with a simple routine | 16.7 | 0 | 2 |
| [Sensitive skin, reactive skin] | 16.7 | 0 | 2 |
| Coiled molecularly imprinted polymer layer open-tubular capillary tube for detection of parabens in personal care and cosmetic products | 16.7 | 0 | 2 |
| Comparison of transepidermal water loss rates in subjects with skin patch test positive vs negative to skin care products | 16.7 | 0 | 2 |
| [Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products] | 16.7 | 0 | 2 |
| Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model | 16.7 | 0 | 2 |
| [Babaodan Capsules for viral hepatitis: systematic review of clinical efficacy and safety and Meta-analysis of randomized clinical trials] | 16.7 | 0 | 2 |
| First case of contact dermatitis caused by C12-13 alkyl malate used in a skin care product for acne | 16.7 | 0 | 2 |
| Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products | 16.7 | 0 | 2 |
| Advances of hyaluronic acid in stem cell therapy and tissue engineering, including current clinical trials | 16.7 | 0 | 2 |
| Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials | 16.7 | 0 | 2 |
| Exploratory study to evaluate two clinical methods for assessing moisturizing effect on skin barrier repair | 16.7 | 0 | 2 |
| Laboratory bioassay exploring the effects of anti-aging skincare products on free-living marine nematodes: a case study of collagen | 16.7 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results: 2015-2016 | 16.7 | 0 | 2 |
| PROMOTING HEALTHY AGING THROUGH PRAGMATIC CLINICAL TRIALS | 16.7 | 0 | 2 |
| Contact Dermatitis Associated With Nail Care Products: Retrospective Analysis of North American Contact Dermatitis Group Data, 2001-2016 | 16.7 | 0 | 2 |
| Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Pla | 16.7 | 0 | 2 |
| Re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network | 16.7 | 0 | 2 |
| Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy | 16.7 | 0 | 2 |
| Allergic contact dermatitis to methylisothiazolinone in hair care products: report of a case | 16.7 | 0 | 2 |
| Practical approaches to skin barrier recovery and maintenance: principles of cleansing for children and adults | 16.7 | 0 | 2 |
| Skin irritation and sensitization of swine acellular dermal matrix treated with hyaluronic acid | 16.7 | 0 | 2 |
| A Prototype Lip Balm: Summary of Three Dermatological Studies Demonstrating Safety and Acceptability for Sensitive Skin | 16.7 | 0 | 2 |
| Devising a Tier-based Skin Sensitisation Screening Strategy for Personal Care and Cosmetic Products | 16.7 | 0 | 2 |
| The dental face mask--the most common cause of work-related face dermatitis in dental nurses | 16.7 | 0 | 2 |
| Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties | 16.7 | 0 | 2 |
| Beauty Shop UK | 16.7 | 0 | 2 |
| Hyaluronic Acid Filler in the Treatment for Drooping Tip: Anatomical Concepts and Clinical Results | 16.7 | 0 | 2 |
| Contact dermatitis caused by glucose sensors - 15 adult patients tested with a medical device patch test series | 16.7 | 0 | 2 |
| European Standard Series Patch Test Results in Contact Dermatitis Patients in a Tertiary Care Hospital | 16.7 | 0 | 2 |
| A Randomized Study of Smile Exercise for Dry Eye | 16.7 | 0 | 2 |
| Induction of Allergic Contact Dermatitis and Pervasive Face Edema due to Brazilian Keratin Treatment | 16.7 | 0 | 2 |
| Topical application of autophagy activating peptide improved skin barrier function and reduced acne symptoms in acne-prone skin | 16.7 | 0 | 2 |
| Effect of Active Ingredients of Chinese Herbal Medicine on the Rejuvenation of Healthy Aging: Focus on Stem Cells | 16.7 | 0 | 2 |
| Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials | 16.7 | 0 | 2 |
| Novel use of lip balm under tracheostomy ties to prevent skin irritation in the pediatric patient | 16.7 | 0 | 2 |
| Q98545425 | 16.7 | 0 | 2 |
| Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study | 16.7 | 0 | 2 |
| Clinical efficacy of ultrasound-guided hyaluronic acid injections in patients with supraspinatus tendon tear | 16.7 | 0 | 2 |
| The application of skin care product in acne treatment | 16.7 | 0 | 2 |
| Invited Discussion on: Hyaluronic Acid Filler in the Treatment of Drooping Tip-Anatomical Concepts and Clinical Results | 16.7 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 16.7 | 0 | 2 |
| ErasmusBlink: A low cost and easy to use measurement system for medical research with diagnostic potential | 16.7 | 0 | 2 |
| Optical coherence tomography for patch test grading: a prospective study on its use for non-invasive diagnosis of allergic contact dermatitis | 16.7 | 0 | 2 |
| Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials | 16.7 | 0 | 2 |
| ARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis | 16.7 | 0 | 2 |
| ARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema | 16.7 | 0 | 2 |
| Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less "allergy- prone" devices Investigation and advice hampered by insufficient material for optimized patch test investigations | 16.7 | 0 | 2 |
| Contact Dermatitis to Personal Care Products is Increasing (but Different!) in Males and Females: North American Contact Dermatitis Group (NACDG) Data, 1996-2016 | 16.7 | 0 | 2 |
| The Utility of an Occupational Contact Dermatitis Patch Test Database in the Analysis of Workplace Prevention Activities in Toronto, Canada | 16.7 | 0 | 2 |
| Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis | 16.7 | 0 | 2 |
| Currently Relevant P-Phenylenediamine Patch Test Reactions Associated with Hair Dye and Non-Scalp Anatomic Areas: Retrospective Cross-Sectional Analysis of North American Contact Dermatitis Group Data, 2001 to 2016 | 16.7 | 0 | 2 |
| Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016) | 16.7 | 0 | 2 |
| Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions | 16.7 | 0 | 2 |
| Preparation and characterization of collagen/chitosan/hyaluronic acid thin films for application in hair care cosmetics | 16.7 | 0 | 2 |
| Challenges and Effective Routes for Formulating and Delivery of Epidermal Growth Factors in Skin Care | 16.7 | 0 | 2 |
| Q104609298 | 16.7 | 0 | 2 |
| Officine Universelle Buly | 16.7 | 0 | 2 |
| OFRA Cosmetics | 16.7 | 0 | 2 |
| A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations | 16.7 | 0 | 2 |
| White Rain | 16.7 | 0 | 2 |
| Obtaining the best value for money in adaptive sequential estimation | 16.7 | 0 | 2 |
| Blockchain for Loyalty Rewards Program Management | 16.7 | 0 | 2 |
| Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis | 16.7 | 0 | 2 |
| Cloré Beauty Supply | 16.7 | 0 | 2 |
| Benefit of coconut‐based hair oil via hair porosity quantification | 16.7 | 0 | 2 |
| The Clinical Efficacy And Safety Of SkinStylus Microneedling System | 16.7 | 0 | 2 |
| 50 Human Subject Repeat Insult Patch Test | 16.7 | 0 | 2 |
| Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test) | 16.7 | 0 | 2 |
| A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines | 16.7 | 0 | 2 |
| Evaluation of Clinical Efficacy of Different Injection Therapies for Treating Humeral Epicondylopathy | 16.7 | 0 | 2 |
| Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test) | 16.7 | 0 | 2 |
| Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid | 16.7 | 0 | 2 |
| Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin | 16.7 | 0 | 2 |
| cosmetic product | 16.7 | 0 | 2 |
| make-up sponge | 16.7 | 0 | 2 |
| skin care tool | 16.7 | 0 | 2 |
| facial sauna product | 16.7 | 0 | 2 |
| foot file | 16.7 | 0 | 2 |
| lotion & sunscreen applicator | 16.7 | 0 | 2 |
| skin care extractor product | 16.7 | 0 | 2 |
| skin care roller product | 16.7 | 0 | 2 |
| skin cleansing brush head | 16.7 | 0 | 2 |
| skin cleansing brushes & system | 16.7 | 0 | 2 |
| nail care product | 16.7 | 0 | 2 |
| cuticle cream & oil | 16.7 | 0 | 2 |
| nail art kits & accessory | 16.7 | 0 | 2 |
| acne treatments & kit | 16.7 | 0 | 2 |
| anti-aging skin care kit product | 16.7 | 0 | 2 |
| body oil | 16.7 | 0 | 2 |
| compressed skin care mask sheet | 16.7 | 0 | 2 |
| baby gift set | 16.7 | 0 | 2 |
| computer starter kit | 16.7 | 0 | 2 |
| skin care product | 16.7 | 0 | 2 |
| facial pore strip | 16.7 | 0 | 2 |
| lip balms & treatment | 16.7 | 0 | 2 |
| medicated lip treatment | 16.7 | 0 | 2 |
| lotion & moisturizer | 16.7 | 0 | 2 |
| skin care masks & peel | 16.7 | 0 | 2 |
| skin insect repellent | 16.7 | 0 | 2 |
| tanning product | 16.7 | 0 | 2 |
| self tanner | 16.7 | 0 | 2 |
| tanning oil & lotion | 16.7 | 0 | 2 |
| toners & astringent | 16.7 | 0 | 2 |
| wart remover | 16.7 | 0 | 2 |
| hair care kit | 16.7 | 0 | 2 |
| hair coloring accessory | 16.7 | 0 | 2 |
| hair loss concealer | 16.7 | 0 | 2 |
| hair loss treatment | 16.7 | 0 | 2 |
| hair permanents & straightener | 16.7 | 0 | 2 |
| hair steamers & heat cap | 16.7 | 0 | 2 |
| shampoo & conditioner | 16.7 | 0 | 2 |
| shampoo & conditioner set | 16.7 | 0 | 2 |
| Evaluating the gentleness of a new professional model sonic skin care brush though non-invasive measurements of the skin barrier | 16.7 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 16.7 | 0 | 2 |
| Hair care booster in powder form and cosmetic product with an organic acid, and method for preparation and use thereof | 16.7 | 0 | 2 |
| Clé de Peau Beauté | 16.7 | 0 | 2 |
| Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials | 16.7 | 0 | 2 |
| Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial | 16.7 | 0 | 2 |
| A Study on the Beauty Action of the High-School Girl with the Beauty, Beauty Products, and Multi-function Beauty Product Interest | 16.7 | 0 | 2 |
| Contact dermatitis from cera alba in a lip balm—An overlooked allergen? | 16.7 | 0 | 2 |
| Climate Smart Regenerative Agriculture to Produce Sustainable Beauty Products: The Case Study of Snail Secretion Filtrate (LX360®) | 16.7 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 16.7 | 0 | 2 |
| Code-promo | 16.7 | 0 | 2 |
| Luxury beauty products purchase behaviour of affluent consumers: the role of brand consciousness and brand distinctiveness in Zimbabwe | 16.7 | 0 | 2 |
| Study of clinical efficacy, safety and tolerability of low cost branded generic antiepileptic drugs in children and adolescents | 16.7 | 0 | 2 |
| Patch Test Results in Patients with Suspected Contact Dermatitis at a Tertiary Care Hospital in a Semiurban Area in Rajasthan: A Cross-sectional Study | 16.7 | 0 | 2 |
| Etiology of Allergic Contact Dermatitis based on Patch Test | 16.7 | 0 | 2 |
| Q127927836 | 16.7 | 0 | 2 |
| 587 Evaluating meaningful change in disease activity as a clinical efficacy measure for clinical trials in cutaneous lupus erythematosus | 16.7 | 0 | 2 |
| 556 Evaluating important change and clearance of disease activity as clinical efficacy measures for clinical trials in dermatomyositis | 16.7 | 0 | 2 |
| Patch Test Results in 169 Patients with Allergic Contact Dermatitis in Malatya | 16.7 | 0 | 2 |
| Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019–2020 | 16.7 | 0 | 2 |
| Extracts of Cherry and Sweet Cherry Fruit as Active Ingredients of Body Wash Formulations | 16.7 | 0 | 2 |
| Perfumes & Companhia | 16.7 | 0 | 2 |
| Ban-on-negotiations in tender procedures: undermining best value for money? | 16.7 | 0 | 2 |
| Synthesis and physical properties of low cost, non toxic, earth abundant p-type CuInS2 thin film as absorber layer for photovoltaic application | 16.7 | 0 | 2 |
| Clinical trials on the way to secure the translational and clinical efficacy | 16.7 | 0 | 2 |
| Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis | 16.7 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 16.7 | 0 | 2 |
| Influence of Brand Ambassador, Brand Awareness, and Price on Brand Image and Purchasing Decision in Halal Skincare Product (Study on MS Glow Skincare Products in Surabaya) | 16.7 | 0 | 2 |
| Tropic | 16.7 | 0 | 2 |
| The Effect of Eco-Friendly Packaging on Consumer Purchase Intention: a Study of Coca-Cola Sustainable Packaging Practices | 16.7 | 0 | 2 |
| Allergic contact dermatitis caused by acrylates in nail cosmetic products: Case reports and review of the literatures | 16.7 | 0 | 2 |
| Receptor-based aggregate exposure estimation for children’s personal care and cosmetic products in Korea | 16.7 | 0 | 2 |
| 682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair | 16.7 | 0 | 2 |
| 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair | 16.7 | 0 | 2 |
| Konga Health | 16.7 | 0 | 2 |
| Nutural Nigerian | 16.7 | 0 | 2 |
| Autodeliver | 16.7 | 0 | 2 |
| Non De-Oiled Rose Water | 16.7 | 0 | 2 |
| DabiDabi | 16.7 | 0 | 2 |
| Beautinow | 16.7 | 0 | 2 |
| Q135293930 | 16.7 | 0 | 2 |
| Xiaomoxuan | 16.7 | 0 | 2 |
| customer loyalty program software | 16.7 | 0 | 2 |
| Ivan Kuzovlev | 16.7 | 0 | 2 |
| indu beauty | 16.7 | 0 | 2 |
| Q136950608 | 16.7 | 0 | 2 |
| Q137176402 | 16.7 | 0 | 2 |
| Authentic Makeup Store BD | 16.7 | 0 | 2 |
| Smooche | 16.7 | 0 | 2 |
| AWARE Hair | 16.7 | 0 | 2 |
| Tanya Kutto | 16.7 | 0 | 2 |
| Dr. Sorbie | 16.7 | 0 | 2 |
| Q138864262 | 16.7 | 0 | 2 |
| HOIA homespa | 16.7 | 0 | 2 |
| BoomCodesNow | 16.7 | 0 | 2 |
| Miraculum S.A. | 16.7 | 0 | 2 |
| Nutrire | 16.7 | 0 | 2 |
| JCBuckman | 16.7 | 0 | 2 |
| M Natural | 16.7 | 0 | 2 |
| MQG Professional | 16.7 | 0 | 2 |
| Realz | 16.7 | 0 | 2 |
| Rinascita | 16.7 | 0 | 2 |
| L'ange Hair, Inc. | 16.7 | 0 | 2 |
| Natural Beauty by KannaValley | 16.7 | 0 | 2 |
| L'ange | 16.7 | 0 | 2 |
| PowerV | 16.7 | 0 | 2 |
| Bloomberg Television | 14.7 | 1 | 0 |
| Bloomberg L.P. | 14.7 | 1 | 0 |
| Hot Latin Songs | 14.7 | 1 | 0 |
| Latin Rhythm Airplay | 14.7 | 1 | 0 |
| Associated Press | 14.7 | 1 | 0 |
| Coco Chanel | 14.7 | 1 | 0 |
| CNN | 14.7 | 1 | 0 |
| Barneys New York | 14.7 | 1 | 0 |
| Q79407 | 14.7 | 1 | 0 |
| Dana Perino | 14.7 | 1 | 0 |
| arXiv | 14.7 | 1 | 0 |
| Dollar General | 14.7 | 1 | 0 |
| Keeping Up with the Kardashians | 14.7 | 1 | 0 |
| Urban Decay | 14.7 | 1 | 0 |
| Kroger | 14.7 | 1 | 0 |
| Jenna Bush Hager | 14.7 | 1 | 0 |
| L'Oréal | 14.7 | 1 | 0 |
| Christian Dior | 14.7 | 1 | 0 |
| The Wall Street Journal | 14.7 | 1 | 0 |
| Nordstrom | 14.7 | 1 | 0 |
| Billboard Hot 100 | 14.7 | 1 | 0 |
| Paris Convention for the Protection of Industrial Property | 14.7 | 1 | 0 |
| Financial Times | 14.7 | 1 | 0 |
| Fox News | 14.7 | 1 | 0 |
| Kim Kardashian | 14.7 | 1 | 0 |
| Billboard 200 | 14.7 | 1 | 0 |
| United States Food and Drug Administration | 14.7 | 1 | 0 |
| New York Post | 14.7 | 1 | 0 |
| Daily Mirror | 14.7 | 1 | 0 |
| Q229883 | 14.7 | 1 | 0 |
| Katie Couric | 14.7 | 1 | 0 |
| dm-drogerie markt | 14.7 | 1 | 0 |
| Laura Ingraham | 14.7 | 1 | 0 |
| Greta Van Susteren | 14.7 | 1 | 0 |
| Kate Spade | 14.7 | 1 | 0 |
| Bloomingdale's | 14.7 | 1 | 0 |
| Estée Lauder | 14.7 | 1 | 0 |
| Megyn Kelly | 14.7 | 1 | 0 |
| McKinsey & Company | 14.7 | 1 | 0 |
| Harrods | 14.7 | 1 | 0 |
| Victoria’s Secret | 14.7 | 1 | 0 |
| Allure | 14.7 | 1 | 0 |
| Reader's Digest | 14.7 | 1 | 0 |
| PR Newswire | 14.7 | 1 | 0 |
| Wireshark | 14.7 | 1 | 0 |
| free will | 10.5 | 0 | 1 |
| vascular endothelial growth factor | 10.5 | 0 | 1 |
| clinical trial | 10.5 | 0 | 1 |
| classical genetics | 10.5 | 0 | 1 |
| Michael Grätzel | 10.5 | 0 | 1 |
| Limited-Edition Vinyl Box Set | 10.5 | 0 | 1 |
| cosmetics | 10.5 | 0 | 1 |
| starry sky | 10.5 | 0 | 1 |
| n-pentane | 10.5 | 0 | 1 |
| red hair | 10.5 | 0 | 1 |
| Unilever | 10.5 | 0 | 1 |
| Boomerang | 10.5 | 0 | 1 |
| hygiene | 10.5 | 0 | 1 |
| Parkinson's law of triviality | 10.5 | 0 | 1 |
| Ryanair | 10.5 | 0 | 1 |
| shampoo | 10.5 | 0 | 1 |
| Rita Levi-Montalcini | 10.5 | 0 | 1 |
| Immaculate Conception of Mary | 10.5 | 0 | 1 |
| newspaper printing | 10.5 | 0 | 1 |
| low-cost airline | 10.5 | 0 | 1 |
| Anatomical Therapeutic Chemical Classification System | 10.5 | 0 | 1 |
| shaving brush | 10.5 | 0 | 1 |
| Roger Y. Tsien | 10.5 | 0 | 1 |
| Beiersdorf | 10.5 | 0 | 1 |
| blond hair | 10.5 | 0 | 1 |
| Warcraft III: Reign of Chaos | 10.5 | 0 | 1 |
| DNA repair | 10.5 | 0 | 1 |
| sunglasses | 10.5 | 0 | 1 |
| I Want to Break Free | 10.5 | 0 | 1 |
| nail polish | 10.5 | 0 | 1 |
| Stanley Cohen | 10.5 | 0 | 1 |
| Clearasil | 10.5 | 0 | 1 |
| Ägyptische Erde | 10.5 | 0 | 1 |
| Analects | 10.5 | 0 | 1 |
| heat shield | 10.5 | 0 | 1 |
| irritant diaper dermatitis | 10.5 | 0 | 1 |
| irritant contact dermatitis due to oils and greases | 10.5 | 0 | 1 |
| deodorant | 10.5 | 0 | 1 |
| Bmibaby | 10.5 | 0 | 1 |
| MCMXC a.D. | 10.5 | 0 | 1 |
| mascara | 10.5 | 0 | 1 |
| Centella asiatica | 10.5 | 0 | 1 |
| hairstyle | 10.5 | 0 | 1 |
| social commerce | 10.5 | 0 | 1 |
| hyaluronic acid | 10.5 | 0 | 1 |
| Richard E. Grant | 10.5 | 0 | 1 |
| afro | 10.5 | 0 | 1 |
| growth factor | 10.5 | 0 | 1 |
| triclosan | 10.5 | 0 | 1 |
| nerve growth factor | 10.5 | 0 | 1 |
| Venetian ceruse | 10.5 | 0 | 1 |